EP
BIOA

Essential Partners’s BioAge Labs BIOA Stock Holding History

Essential Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35K Sell
96
-12
-11% -$217 ﹤0.01% 1909
2026
Q1 		$1.89K Hold
108
– – ﹤0.01% 2031
2025
Q4 		$1.43K Buy
108
+51
+89% +$452 ﹤0.01% 1911
2025
Q3 		$335 Buy
57
+13
+30% +$61 ﹤0.01% 2292
2025
Q2 		$182 Buy
+44
New +$177 ﹤0.01% 1970

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Essential Partners's BIOA Position: Q2 2026 in Review

Essential Partners reduced its BioAge Labs (BIOA) stake by 11% in Q2 2026, selling an estimated $217 and leaving 96 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

Essential Partners first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Essential Partners held 96 shares of BioAge Labs worth $2.35K as of Q2 2026.
  • Essential Partners sold 12 BioAge Labs shares in Q2 2026, an estimated $217.
  • BioAge Labs made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1909 holding.
  • Essential Partners first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.